34
Participants
Start Date
March 31, 2009
Primary Completion Date
December 31, 2011
Study Completion Date
January 31, 2016
SOM230C
Injection in the buttocks every 28 days
Memorial Sloan Kettering Cancer Center, New York
Wake Forest University Baptist Medical Center, Winston-Salem
Duke University Medical Center, Preston Robert Tisch Brain Tumor Center, Durham
Northwestern University, Chicago
Cedars-Sinai Medical Center, Los Angeles
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
Collaborators (2)
Brigham and Women's Hospital
OTHER
Massachusetts General Hospital
OTHER
Beth Israel Deaconess Medical Center
OTHER
Memorial Sloan Kettering Cancer Center
OTHER
Wake Forest University Health Sciences
OTHER
Duke University
OTHER
Cedars-Sinai Medical Center
OTHER
Northwestern University
OTHER
Novartis
INDUSTRY
Patrick Y. Wen, MD
OTHER